000 01583 a2200409 4500
005 20250518091116.0
264 0 _c20210902
008 202109s 0 0 eng d
022 _a1573-0646
024 7 _a10.1007/s10637-020-00920-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBroekman, K Esther
245 0 0 _aPhase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer.
_h[electronic resource]
260 _bInvestigational new drugs
_c10 2020
300 _a1454-1462 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aCarboplatin
_xadministration & dosage
650 0 4 _aCarcinoma, Ovarian Epithelial
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMetformin
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aPaclitaxel
_xadministration & dosage
700 1 _aHof, Marieke A J
700 1 _aTouw, Daan J
700 1 _aGietema, Jourik A
700 1 _aNijman, Hans W
700 1 _aLefrandt, Joop D
700 1 _aReyners, An K L
700 1 _aJalving, Mathilde
773 0 _tInvestigational new drugs
_gvol. 38
_gno. 5
_gp. 1454-1462
856 4 0 _uhttps://doi.org/10.1007/s10637-020-00920-7
_zAvailable from publisher's website
999 _c30717158
_d30717158